Inhibition of the LncRNA Gpr19 attenuates ischemia-reperfusion injury after acute myocardial infarction by inhibiting apoptosis and oxidative stress via the miR-324-5p/Mtfr1 axis
- PMID: 31622017
- DOI: 10.1002/iub.2187
Inhibition of the LncRNA Gpr19 attenuates ischemia-reperfusion injury after acute myocardial infarction by inhibiting apoptosis and oxidative stress via the miR-324-5p/Mtfr1 axis
Abstract
Reperfusion therapy after acute myocardial infarction (AMI) can effectively restore the blood supply and nutritional support of ischemic myocardium and save the dying myocardium. However, myocardial ischaemia-reperfusion (I/R) injury has become a new threat to reperfusion therapy for AMI. Many long-chain noncoding RNAs (lncRNAs) are dysregulated by I/R damage. Of these dysregulated lncRNAs, Gpr19 was selected as a potential gene of interest based on its high expression change. We aimed to explore the functional role and molecular mechanism of Gpr19 in I/R injury of AMI. C57BL/6 mice underwent I/R injury as in vivo models. Neonatal rat ventricular cardiomyocytes (NRCMs) exposed to an oxygen glucose deprivation/recovery (OGD/R) system were used as an in vitro model. A TUNEL assay, western blot, and oxidative stress analysis were conducted in this study to determine apoptosis and oxidative stress levels. Our results indicated that inhibition of Gpr19 improves cardiac function and reduces apoptosis and myocardial fibrosis scar formation in vivo. Suppression of Gpr19 attenuates oxidative stress and apoptosis in NRCMs exposed to OGD/R. We further demonstrated that inhibition of Gpr19 decreases oxidative stress and apoptosis in OGD/R-induced NRCMs by regulating miR-324-5p and mitochondrial fission regulator 1 (Mtfr1). We elucidated the functional role and potential molecular mechanism of Gpr19 in I/R injury of AMI, provided a theoretical basis for the importance of Gpr9 in I/R injury, and provided a new perspective for the clinical treatment of I/R injury of AMI.
Keywords: I/R injury; LncRNA Gpr19; Mtfr1; acute myocardial infarction; miR-324-5p.
© 2019 International Union of Biochemistry and Molecular Biology.
References
REFERENCES
-
- Alessenko AV, Zateyshchikov DA, Lebedev Acapital Te C, Kurochkin IN. Participation of sphingolipids in the pathogenesis of atherosclerosis. Kardiologiia. 2019;59:77-87.
-
- Abogresha NM, Greish SM, Abdelaziz EZ, Khalil WF. Remote effect of kidney ischemia-reperfusion injury on pancreas: Role of oxidative stress and mitochondrial apoptosis. Arch Med Sci. 2016;12:252-262.
-
- Mehta S, Botelho R, Cade J, et al. Global challenges and solutions: Role of telemedicine in st-elevation myocardial infarction interventions. Interventional Cardiol Clin. 2016;5:569-581.
-
- Larson DM, McKavanagh P, Henry TD, Cantor WJ. Reperfusion options for st elevation myocardial infarction patients with expected delays to percutaneous coronary intervention. Intervent Cardiol Clin. 2016;5:439-450.
-
- Zhao Z, Cui W, Zhang H, et al. Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial katp channel. Eur J Pharmacol. 2015;751:89-98.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases